Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Tumori|April 25, 2015
Investigation of prognostic factors affecting efficacy in carboplatin- and paclitaxel-based first-line chemotherapies for advanced non-small-cell lung cancerMasato Komuro, Masayuki Kaneko, Mamoru Narukawa
Biochemical and Biophysical Research Communications|September 11, 2004
Characterization of Smubp-2 as a mouse mammary tumor virus promoter-binding proteinFumiaki Uchiumi, Masato Komuro, Ryushin Mizuta, et al.
Journal of Medical Systems|August 5, 2026
Temporal Variability in Diagnosis Code Distributions Across Extraction Time Points in a Multicenter Integrated EHR Database: A Snapshot Comparison StudyKyunghee Lee, Chihiro Kumagai, Masato Komuro, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 3, 2026
Concerns and Consultation Needs for Hospital and Community Pharmacists at Metastatic or Recurrent Cancer Diagnosis: A Web-Based Survey in JapanTomofumi Watanabe, Atsunobu Sagara, Tomoya Abe, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 8, 2025
Usefulness of hydrocortisone prophylaxis for oxaliplatin-induced hypersensitivity reactions: A retrospective studyMaho Tanaka, Masato Komuro, Yasushi Kojima, et al.
Journal of Pharmaceutical Health Care and Sciences|July 10, 2025
Cross-sectional survey on cancer patients' concerns and consultation needs with pharmacists at the time of initial diagnosisTomofumi Watanabe, Atsunobu Sagara, Tomoya Abe, et al.
BMC Geriatrics|August 21, 2024
Polypharmacy and potentially inappropriate medications in older adults who use long-term care services: a cross-sectional studyShotaro Hagiwara, Jun Komiyama, Masao Iwagami, et al.
Global Health & Medicine|September 2, 2024
A retrospective single institutional analysis of outpatient chemotherapy in patients with cancer during the COVID-19 pandemicYumiko Shimanuki, Akihiko Shimomura, Chiaki Ogawa, et al.
Expert Opinion on Biological Therapy|June 26, 2024
Comparative analysis of GMO regulatory requirements for AAV vectors in the EU and Japan focusing on the shedding data and containment measuresHirokuni Mizoguchi, Tobias Fleischmann, Masato Komuro, et al.
Regenerative Therapy|July 22, 2024
Regulatory systems and requirements for clinical trials of AAV-based gene therapies - Perspectives from six Asian countries or regions: Report from the 6th Asia Partnership Conference of Regenerative Medicine - April 20, 2023Hirokuni Mizoguchi, Alex J Zhang, Pawan Kumar Gupta, et al.
Pageof 2